Ing Investment Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Ing Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $22M 18M 1.19
2024-06-30 $16M 15M 1.11

More positions owned by Ing Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Servicenow (NOW)
JPMorgan Chase & Co. (JPM)
Wells Fargo Perp Pfd Cnv A (WFC.PL)
Palo Alto Networks (PANW)
Datadog Cl A Com (DDOG)

View all positions for Ing Investment Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1